increased expression in tumor tissues

Production Environment

Cooperation partner

increased expression in tumor tissues

Increased PADI4 expression in blood and tissues of ...- increased expression in tumor tissues ,Methods: Expression of PADI4 was investigated in various tumors and non-tumor tissues (n = 1673) as well as in A549, SKOV3 and U937 tumor cell lines by immunohistochemistry, real-time PCR, and western blot. Levels of PADI4 and citrullinated antithrombin (cAT) were investigated in the blood of patients with various tumors by ELISA (n = 1121).Autophagy-associated circRNA circATG7 facilitates ...Mar 14, 2022·Moreover, KI67, PCNA, and LC3 expression was increased in tissues overexpressing circATG7, while P62 expression was decreased. ... C The weight of tumor tissues with circATG7 overexpression and ...



Increased Expression of UDP-Galactose Transporter ...

Jun 01, 2001·The increase was more prominent in patients with advanced colorectal cancer of Dukes’ stages C and D, in which the amount of UDP-Gal transporter mRNA in cancer tissues showed on average about a 3.6-fold increase over the paired nonmalignant mucosa (statistically significant at P = 0.004; n = 14). The mRNA content of the other two transporters ...

[Increased expression of IGF-2 in tumor tissue of ...

[Increased expression of IGF-2 in tumor tissue of nephroblastoma]. [Article in German] Briner J, Hassam S, Schönle EJ, Rohrer U. The incidence of nephroblastoma is increased in a number of syndromes with abnormal growth pattern. Elevated IGF 2-expression has been documented in various Wilms' tumors and a defect in the IGF 2 gene has been noted ...

Increased Expression of COX-2 in Nontumor Liver Tissue Is ...

COX-2 expression in nontumor tissue and shorter disease-free survival (P 5 0.0132). Moreover, high COX-2 expres-sion in nontumor tissue was significantly correlated with the presence of active inflammation (P < 0.0001). The present findings suggest that COX-2 expression in nontumor tissue may play a positive role in relapse of HCC after surgery.

Increased expression of peptides from non-coding genes in ...

Apr 22, 2021·Differential expressed noncoding gene-encoded peptides between tumor and normal tissue. We investigated if certain pseudogene/lncRNA-encoded peptides had elevated expression in tumors in the colorectal cancer (CRC) dataset with 8 paired CRC samples and matched normal tissues (PXD002137) 27. In this dataset, 73 pseudogenes and lncRNAs …

p15PAF, a novel PCNA associated factor with increased ...

Mar 12, 2001·p15 PAF expression is increased in tumor tissues. PCNA expression has been correlated to tumor progression and is commonly used as a molecular marker for detecting hyperplastic cell growth.

Increased angiogenin expression in the tumor tissue and ...

Background: The progression of solid tumors is at least partly dependent on angiogenesis, the induction of which is mediated by several angiogenic factors, including angiogenin (ANG). The authors evaluated the expression of ANG in the tumor tissue and serum of patients with urothelial carcinoma. Methods: The expression of ANG in 5 human bladder carcinoma cell …

Increased expression of peptides from non-coding genes in ...

Apr 22, 2021·Differential expressed noncoding gene-encoded peptides between tumor and normal tissue. We investigated if certain pseudogene/lncRNA-encoded peptides had elevated expression in tumors in the colorectal cancer (CRC) dataset with 8 paired CRC samples and matched normal tissues (PXD002137) 27. In this dataset, 73 pseudogenes and lncRNAs …

Increased angiogenin expression in the tumor tissue and ...

Background: The progression of solid tumors is at least partly dependent on angiogenesis, the induction of which is mediated by several angiogenic factors, including angiogenin (ANG). The authors evaluated the expression of ANG in the tumor tissue and serum of patients with urothelial carcinoma. Methods: The expression of ANG in 5 human bladder carcinoma cell …

[Increased expression of IGF-2 in tumor tissue of ...

[Increased expression of IGF-2 in tumor tissue of nephroblastoma]. [Article in German] Briner J, Hassam S, Schönle EJ, Rohrer U. The incidence of nephroblastoma is increased in a number of syndromes with abnormal growth pattern. Elevated IGF 2-expression has been documented in various Wilms' tumors and a defect in the IGF 2 gene has been noted ...

GLUT1 and ASCT2 protein expression in thyroid cancer | IJGM

GULT1 showed variable expression in PTC samples with recorded high expression (in more than 75% of tumor tissue). Nearly 85% of PTC cases were positively expressed GLUT1 that was mainly cytoplasmic with associated nuclear staining. For cancer tissue expression of GLUT 1, we had more than half of the cases weakly express the marker (59%).

Increased PADI4 expression in blood and tissues of ...

Methods: Expression of PADI4 was investigated in various tumors and non-tumor tissues (n = 1673) as well as in A549, SKOV3 and U937 tumor cell lines by immunohistochemistry, real-time PCR, and western blot. Levels of PADI4 and citrullinated antithrombin (cAT) were investigated in the blood of patients with various tumors by ELISA (n = 1121).

Increased expression of peptides from non-coding genes in ...

Apr 22, 2021·Differential expressed noncoding gene-encoded peptides between tumor and normal tissue. We investigated if certain pseudogene/lncRNA-encoded peptides had elevated expression in tumors in the colorectal cancer (CRC) dataset with 8 paired CRC samples and matched normal tissues (PXD002137) 27. In this dataset, 73 pseudogenes and lncRNAs …

GLUT1 and ASCT2 protein expression in thyroid cancer | IJGM

GULT1 showed variable expression in PTC samples with recorded high expression (in more than 75% of tumor tissue). Nearly 85% of PTC cases were positively expressed GLUT1 that was mainly cytoplasmic with associated nuclear staining. For cancer tissue expression of GLUT 1, we had more than half of the cases weakly express the marker (59%).

p15PAF, a novel PCNA associated factor with increased ...

Mar 12, 2001·p15 PAF expression is increased in tumor tissues. PCNA expression has been correlated to tumor progression and is commonly used as a molecular marker for detecting hyperplastic cell growth.

A Comparative Study of HOTAIR Expression in Breast Cancer ...

There is no significant difference in the expression of HOTAIR in both of MCF-7 and MDA-MB-231 cancer cell lines compared to normal cell line MCF-10A (P>0.05) and B. Breast cancer compared to normal breast tissues. There is a significant increase in the expression level of HOTAIR in patients with breast cancer compared to the controls (P<0.001).

Increased PADI4 expression in blood and tissues of ...

Jan 30, 2009·Peptidylarginine deiminase type 4 (PAD4/PADI4) post-translationally converts peptidylarginine to citrulline. Recent studies suggest that PADI4 represses expression of p53-regulated genes via citrullination of histones at gene promoters. Expression of PADI4 was investigated in various tumors and non-tumor tissues (n = 1673) as well as in A549, SKOV3 …

Increased expression of peptides from non-coding genes …

Apr 22, 2021·Differential expressed noncoding gene-encoded peptides between tumor and normal tissue. We investigated if certain pseudogene/lncRNA-encoded peptides had elevated expression in tumors in the colorectal cancer (CRC) dataset with 8 paired CRC samples and matched normal tissues (PXD002137) 27. In this dataset, 73 pseudogenes and lncRNAs …

Increased Expression of COX-2 in Nontumor Liver Tissue Is ...

COX-2 expression in nontumor tissue and shorter disease-free survival (P 5 0.0132). Moreover, high COX-2 expres-sion in nontumor tissue was significantly correlated with the presence of active inflammation (P < 0.0001). The present findings suggest that COX-2 expression in nontumor tissue may play a positive role in relapse of HCC after surgery.

A Comparative Study of HOTAIR Expression in Breast Cancer ...

There is no significant difference in the expression of HOTAIR in both of MCF-7 and MDA-MB-231 cancer cell lines compared to normal cell line MCF-10A (P>0.05) and B. Breast cancer compared to normal breast tissues. There is a significant increase in the expression level of HOTAIR in patients with breast cancer compared to the controls (P<0.001).

Increased Expression of UDP-Galactose ... - Cancer Research

[CANCER RESEARCH 61, 4620–4627, June 1, 2001] Increased Expression of UDP-Galactose Transporter Messenger RNA in Human Colon Cancer Tissues and Its Implication in Synthesis of Thomsen-Friedenreich Antigen and Sialyl Lewis A/X Determinants1 Kensuke Kumamoto, Yoshiko Goto, Koji Sekikawa, Seiichi Takenoshita, Nobuhiro Ishida, Masao Kawakita, and

Increased Expression of UDP-Galactose Transporter ...

Jun 01, 2001·The increase was more prominent in patients with advanced colorectal cancer of Dukes’ stages C and D, in which the amount of UDP-Gal transporter mRNA in cancer tissues showed on average about a 3.6-fold increase over the paired nonmalignant mucosa (statistically significant at P = 0.004; n = 14). The mRNA content of the other two transporters ...

Increased pontin expression in human colorectal cancer …

Jul 01, 2007·Tumor stage: pT3N0G2M0 (A); pT2N0G3M0 (B); pT2N0G2M0 (C); pT2N2G2M0 (D). Quantification on a FujiFilm LAS-1000 system revealed a 4-, 7-, 4-, and 8-fold increase of pontin protein expression in the tumor samples compared with normal tissue, respectively. Four of 8 tumor samples are shown as representatives.

Increased expression of thymidine phosphorylase in tumor ...

Sep 01, 2004·There was a significant correlation between the expression of TP in tumor tissue and adjacent normal tissue (R=0.711, p<0.001; y=23.420+1.534x). On the other hand, there was no significant correlation between the ratio of tumor to adjacent normal tissue levels of TP (TP T/N) and expression of TP in tumor tissue (R=0.250, p=0.110).

Increased Expression of UDP-Galactose Transporter ...

Jun 01, 2001·The increase was more prominent in patients with advanced colorectal cancer of Dukes’ stages C and D, in which the amount of UDP-Gal transporter mRNA in cancer tissues showed on average about a 3.6-fold increase over the paired nonmalignant mucosa (statistically significant at P = 0.004; n = 14). The mRNA content of the other two transporters ...